Sign in

    Prof. Ugur Sahin, M.D.

    CEO and Co-Founder at BBiontech SE
    Board
    Since N/A
    Age
    58 years
    Education
    Holds a medical degree (M.D.) from Johannes Gutenberg University in Mainz, Germany.
    Tenure
    Co-founded BioNTech and currently serves as its CEO, playing a pivotal role in shaping the company's strategy, innovation, and advancement of novel therapies.

    Also at Biontech SE

    JH
    Jens Holstein
    Chief Financial Officer (CFO)
    RR
    Ryan Richardson
    Chief Strategy Officer (CSO)
    SM
    Sean Marett
    Chief Business Officer (CBO) and Chief Commercial Officer (CCO)

    About

    As the CEO and Co-Founder of BioNTech, he has been instrumental in transforming the company into a global leader in immunotherapy and vaccine development, driving both research innovation and strategic growth.

    His leadership has been marked by significant contributions to advancing oncology pipelines, including the development of mRNA cancer vaccines, antibody-drug conjugates, and CAR-T therapies, as well as the successful commercialization of a COVID-19 vaccine.

    In addition to his role in leading breakthrough scientific initiatives, he has championed the integration of artificial intelligence into the discovery process, emphasizing personalized medicine and the development of novel therapeutic solutions.

    Although detailed information about his early personal background is limited, his professional journey and ongoing impact at BioNTech underscore his commitment to advancing global healthcare through innovative biotechnology.

    $BNTX Performance Under Prof. Ugur Sahin, M.D.

    External Roles

    OrganizationRoleDate RangeDetails
    Johannes Gutenberg University, Mainz Full Professor (W3) in Translational Oncology & Immunology N/A Supervised more than 50 Ph.D. students
    Helmholtz Institute for Translational Oncology (HI-TRON), Mainz Chair of the Scientific Management Board N/A N/A